FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116781637> ?p ?o ?g. }

• W2116781637 endingPage "e142" @default.
• W2116781637 startingPage "e132" @default.
• W2116781637 abstract "<i>Background:</i> Sairei-to (TJ-114) is a Japanese herbal medicine of standardized quality, originating from traditional Chinese medicine. In the present in vivo study, we investigated the suppressive effects of TJ-114 and related drugs, Shosaiko-to (TJ-9), and Saiboku-to (TJ-96), on mesangioproliferative glomerulonephritis (MsPGN) in rats. TJ-9 is a basal prescription of TJ-96 and TJ-114. We evaluated the efficacy of these drugs on proteinuria, extracellular matrix (ECM) accumulation, and superoxide dismutase (SOD)-activity. <i>Methods:</i> MsPGN in Wistar rats was induced by intravenous injection of rabbit anti-rat thymocyte serum (ATS). TJ-114, TJ-9, TJ-96 (500 mg/kg/day), or prednisolone (PSL, 2 mg/kg/day) was orally administered to the rats as drinking water from the day of ATS injection (day 0) to day 8, when rats were sacrificed and the kidney specimens were collected. Macrophage infiltration was evaluated by immunostaining for ED-1. ECM was measured by trichrome-staining, and fibronectin immunostaining. Northern blotting was performed to clarify the mRNA expression of cytokines and fibronectin. SOD-activity in the homogenate of renal cortex was also evaluated. <i>Results:</i> The amount of urinary protein was significantly decreased only in the TJ-114-treated group compared with the disease control group (p < 0.05). The number of ED-1-positive cells was significantly decreased in all the treatment groups (p < 0.05, respectively). Decreases in the trichrome-stained area were observed moderately in the TJ-114-treated group (66% of control, p < 0.001) and mildly in the PSL-treated group (76% of control, p < 0.001). The staining area of fibronectin in the glomerulus was significantly decreased in all the treated groups except PSL, and was especially suppressed in the TJ-114-treated group (45% of control, p < 0.001). Transforming growth factor (TGF) and connective tissue growth factor (CTGF) expression significantly decreased in the TJ-114-treated group to the control level (p < 0.05). TGF-β, CTGF, and fibronectin mRNA were upregulated in the disease control group, and TJ-114 suppressed these mRNA expressions in glomeruli. The SOD-activity of renal cortex-homogenate was significantly augmented in all the treated groups except PSL, markedly in the TJ-96- and TJ-114-treated groups. <i>Conclusion:</i> These results suggest that TJ-114 ameliorates ECM accumulation in experimental rat MsPGN, partly suppressing TGF-β and CTGF expression through the recovery of SOD-activity." @default.
• W2116781637 created "2016-06-24" @default.
• W2116781637 creator A5004173335 @default.
• W2116781637 creator A5009867090 @default.
• W2116781637 creator A5033364831 @default.
• W2116781637 creator A5035998238 @default.
• W2116781637 creator A5057390834 @default.
• W2116781637 creator A5057415800 @default.
• W2116781637 creator A5070870688 @default.
• W2116781637 date "2005-04-15" @default.
• W2116781637 modified "2023-10-18" @default.
• W2116781637 title "Suppressive Mechanisms of Sairei-to on Mesangial Matrix Expansion in Rat Mesangioproliferative Glomerulonephritis" @default.
• W2116781637 cites W142717363 @default.
• W2116781637 cites W1585531042 @default.
• W2116781637 cites W1792882180 @default.
• W2116781637 cites W1981614796 @default.
• W2116781637 cites W1985132240 @default.
• W2116781637 cites W1989279844 @default.
• W2116781637 cites W1998156838 @default.
• W2116781637 cites W2004560721 @default.
• W2116781637 cites W2027693573 @default.
• W2116781637 cites W2052996694 @default.
• W2116781637 cites W2054418276 @default.
• W2116781637 cites W2061570941 @default.
• W2116781637 cites W2064675678 @default.
• W2116781637 cites W2065341814 @default.
• W2116781637 cites W2068688260 @default.
• W2116781637 cites W2082230217 @default.
• W2116781637 cites W2086888085 @default.
• W2116781637 cites W2114623735 @default.
• W2116781637 cites W2117329473 @default.
• W2116781637 cites W2122603733 @default.
• W2116781637 cites W2126808290 @default.
• W2116781637 cites W2129593063 @default.
• W2116781637 cites W2134812217 @default.
• W2116781637 cites W2138668353 @default.
• W2116781637 cites W2146559746 @default.
• W2116781637 cites W2148363897 @default.
• W2116781637 cites W2154186340 @default.
• W2116781637 cites W2156050131 @default.
• W2116781637 cites W2156436523 @default.
• W2116781637 cites W2173662262 @default.
• W2116781637 cites W2268662899 @default.
• W2116781637 cites W2316890325 @default.
• W2116781637 cites W2322258669 @default.
• W2116781637 cites W2417370996 @default.
• W2116781637 cites W2418880412 @default.
• W2116781637 cites W2471337475 @default.
• W2116781637 cites W2596148995 @default.
• W2116781637 doi "https://doi.org/10.1159/000085059" @default.
• W2116781637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15824516" @default.
• W2116781637 hasPublicationYear "2005" @default.
• W2116781637 type Work @default.
• W2116781637 sameAs 2116781637 @default.
• W2116781637 citedByCount "19" @default.
• W2116781637 countsByYear W21167816372013 @default.
• W2116781637 countsByYear W21167816372014 @default.
• W2116781637 countsByYear W21167816372015 @default.
• W2116781637 countsByYear W21167816372016 @default.
• W2116781637 countsByYear W21167816372017 @default.
• W2116781637 countsByYear W21167816372022 @default.
• W2116781637 crossrefType "journal-article" @default.
• W2116781637 hasAuthorship W2116781637A5004173335 @default.
• W2116781637 hasAuthorship W2116781637A5009867090 @default.
• W2116781637 hasAuthorship W2116781637A5033364831 @default.
• W2116781637 hasAuthorship W2116781637A5035998238 @default.
• W2116781637 hasAuthorship W2116781637A5057390834 @default.
• W2116781637 hasAuthorship W2116781637A5057415800 @default.
• W2116781637 hasAuthorship W2116781637A5070870688 @default.
• W2116781637 hasConcept C126322002 @default.
• W2116781637 hasConcept C134018914 @default.
• W2116781637 hasConcept C163031210 @default.
• W2116781637 hasConcept C185592680 @default.
• W2116781637 hasConcept C189165786 @default.
• W2116781637 hasConcept C204232928 @default.
• W2116781637 hasConcept C2779561371 @default.
• W2116781637 hasConcept C2780091579 @default.
• W2116781637 hasConcept C2780559512 @default.
• W2116781637 hasConcept C2780688133 @default.
• W2116781637 hasConcept C4224716 @default.
• W2116781637 hasConcept C55493867 @default.
• W2116781637 hasConcept C71924100 @default.
• W2116781637 hasConcept C86492073 @default.
• W2116781637 hasConceptScore W2116781637C126322002 @default.
• W2116781637 hasConceptScore W2116781637C134018914 @default.
• W2116781637 hasConceptScore W2116781637C163031210 @default.
• W2116781637 hasConceptScore W2116781637C185592680 @default.
• W2116781637 hasConceptScore W2116781637C189165786 @default.
• W2116781637 hasConceptScore W2116781637C204232928 @default.
• W2116781637 hasConceptScore W2116781637C2779561371 @default.
• W2116781637 hasConceptScore W2116781637C2780091579 @default.
• W2116781637 hasConceptScore W2116781637C2780559512 @default.
• W2116781637 hasConceptScore W2116781637C2780688133 @default.
• W2116781637 hasConceptScore W2116781637C4224716 @default.
• W2116781637 hasConceptScore W2116781637C55493867 @default.
• W2116781637 hasConceptScore W2116781637C71924100 @default.
• W2116781637 hasConceptScore W2116781637C86492073 @default.
• W2116781637 hasIssue "3" @default.

• next